Amanote Research
Register
Sign In
Aberrant Subcellular Expression of Nucleophosmin and NPM-MLF1 Fusion Protein in Acute Myeloid Leukaemia Carrying T(3;5): A Comparison With NPMc+ AML
Leukemia
- United Kingdom
doi 10.1038/sj.leu.2404164
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
March 9, 2006
Authors
Unknown
Publisher
Springer Nature
Related search
Aberrant Subcellular Expression of Nucleophosmin and NPM-MLF1 Fusion Protein in Acute Myeloid Leukaemia Carrying T(3;5): A Comparison With NPMc+ AML
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
DNA Damage Corrects the Aberrant Cytoplasmic Localisation of Nucleophosmin in NPM1 Mutated Acute Myeloid Leukaemia
British Journal of Haematology
Hematology
Acute Myeloid Leukemia Bearing Cytoplasmic Nucleophosmin (NPMc+ AML) Shows a Distinct Gene Expression Profile Characterized by Up-Regulation of Genes Involved in Stem-Cell Maintenance
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Psy68 - Costs Associated With Management of Acute Myeloid Leukaemia (Aml) Patients in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
MLL Gene Alterations in Acute Myeloid Leukaemia (11q23/Mll+ AML)
Immunophenotypic Characterisation of Morphologically Diagnosed Cases of Acute Myeloid Leukaemia (AML)
Pakistan Journal of Medical Sciences
Medicine
Identification of a Novel TFG–FGFR1 Fusion Gene in an Acute Myeloid Leukaemia Patient With T(3;8)(q12;p11)
British Journal of Haematology
Hematology
Identification of a Novel RUNX1-TACC1 Fusion Transcript in Acute Myeloid Leukaemia
British Journal of Haematology
Hematology
Quantitative Assessment of Minimal Residual Disease in Acute Myeloid Leukemia Carrying Nucleophosmin (NPM1) Gene Mutations
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
